AC
AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PRIVATE LIMITED (Jointly holding)
Executive
Other
Browse the complete record of transactions filed by AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PRIVATE LIMITED (Jointly holding), Executive. Director active across 1 company, notably Aurobindo Pharma Limited. Cumulatively, 14 filings have been recorded. Activity tracked since 5 July 2021. The latest transaction was disclosed on 24 February 2023 (Pledge). Regulator: SEBI (PIT + SAST). All data is openly available.
Declarations14 total
3,750,000 shares@ ₹469.2511.4% of flowEquity SharesSEBI:0b74245ffa155d479594bf6019fccaec54780a01
3,106,000 shares@ ₹668.8013.9% of flowEquity SharesSEBI:c8880618ce3456e7c5aef28a3b89514b33c4efbf
15,000 shares@ ₹660.250.1% of flowEquity SharesSEBI:8a69fcf4ce258abbb8457222cf9455f6ab96e20d
151,000 shares@ ₹650.950.7% of flowEquity SharesSEBI:23d304b16815f5e4a28c8840922f45dd9c59acc5
4,000,000 shares@ ₹650.9517.6% of flowEquity SharesSEBI:f3405f82ff5e8246fb85c8c54367f3a104c3fece
3,750,000 shares@ ₹650.9516.5% of flowEquity SharesSEBI:f67571ee4ac58b2d0c7571c736593144ee659917
265,000 shares@ ₹738.050.0003% mcap3.2% of flowEquity SharesSEBI:bf9f5b3066cdbde6c1c6f88fd59dc164bf188d46
205,000 shares@ ₹738.050.0003% mcap2.5% of flowEquity SharesSEBI:72de42763e8b45bf5f8816867703f56b95c58e0e
120,000 shares@ ₹761.300.0002% mcap1.5% of flowEquity SharesSEBI:31fa901da1f6cf366ec088cda3ed51ba76c28062
400,000 shares@ ₹761.300.0005% mcap4.9% of flowEquity SharesSEBI:4a8819b731469379fda37482b635c01ef4584dd3
2,630,000 shares@ ₹856.500.0038% mcap36.6% of flowEquity SharesSEBI:f287dcff8acaa88ab671684ba19a11f309ab7a30
10,000 shares@ ₹951.250.0000% mcap0.2% of flowEquity SharesSEBI:6087666165bfaf5157ed5fd6939a75af4d4de97f
1,250,000 shares@ ₹948.700.0020% mcap19.0% of flowEquity SharesSEBI:e32943dd7ad63d7b6d6622e24f1b2810db6db9d7
2,000,000 shares@ ₹1,002.600.0034% mcap32.2% of flowEquity SharesSEBI:0fbc7217550c2ea50dd9319d1c363435279d2e79
About AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PRIVATE LIMITED (Jointly holding)
AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, and RPR SONS ADVISORS PRIVATE LIMITED jointly hold shares in Aurobindo Pharma Limited. These entities play an important role in the strategic direction and management of the company's operations. Their commitment to innovation and quality is essential for Aurobindo Pharma's success.